What we are doing
The National Mesothelioma Audit (NMA) is commissioned and funded by Mesothelioma UK, a charity that provides specialist mesothelioma information and improved care.
Commissioned by and working in partnership with Mesothelioma UK to deliver the national mesothelioma audit (NMA), we have published a number of audit reports to raise the profile of this asbestos-related cancer and to make recommendations on improving the outcomes for mesothelioma patients.
There are four main aims for the mesothelioma audit:
- maintain and enhance the profile of mesothelioma, a disease with poor outcome and variation in care
- build upon the recommendations of the previous mesothelioma report and allow organisations to measure and demonstrate improvement over time
- embed a process of data collection for mesothelioma in clinical teams linked to an infrastructure that has a robust long-term future
- set new standards for mesothelioma.
What is mesothelioma?
Malignant mesothelioma (MM) is a type of cancer that develops over a long period of time and commonly originates in mesothelial cells found in the thin membrane (pleura) that lines the lungs and the inside of the chest wall (malignant pleural mesothelioma – MPM). Mesothelioma can also affect the similar peritoneal membrane within the abdominal cavity (peritoneal mesothelioma – PM). Approximately 2,500 people per year are diagnosed in the UK.
